Scarica l'app Stockscreener
4.92
2.50%
0.12
Orchestra Biomed Holdings Inc Borsa (OBIO) Ultime notizie
Orchestra BioMed CFO Taylor Lawrence buys $4,830 in company stock - Investing.com
Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Buys 5,000 Shares of Stock - MarketBeat
Orchestra Biomed CEO David Hochman buys $24,550 in stock By Investing.com - Investing.com South Africa
Orchestra Biomed CEO David Hochman buys $24,550 in stock - Investing.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stock Position Lowered by The Manufacturers Life Insurance Company - Defense World
(OBIO) Pivots Trading Plans and Risk Controls - Stock Traders Daily
OBIOOrchestra BioMed Holdings, Inc. Ordinary Shares Latest Stock News & Market Updates - StockTitan
Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting - GlobeNewswire
Orchestra BioMed to Present Breakthrough AVIM Therapy Data for Hypertension Treatment at ICI 2024 - StockTitan
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Tops Revenue Estimates - MSN
RTW Investments LP Has $42.18 Million Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - MarketBeat
Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire
Orchestra BioMed to Present at Piper Sandler Healthcare Conference | OBIO Stock News - StockTitan
Orchestra BioMed to Present at Jefferies London Healthcare Conference - MSN
HC Wainwright Has Positive Estimate for OBIO FY2024 Earnings - MarketBeat
HC Wainwright Has Optimistic Outlook of OBIO FY2024 Earnings - Defense World
Research Analysts Offer Predictions for OBIO FY2024 Earnings - Defense World
What is Chardan Capital's Forecast for OBIO FY2024 Earnings? - MarketBeat
B. Riley Lifts Earnings Estimates for Orchestra BioMed - MarketBeat
Orchestra BioMed (NASDAQ:OBIO) Earns "Buy" Rating from HC Wainwright - MarketBeat
Chardan Capital Reaffirms Buy Rating for Orchestra BioMed (NASDAQ:OBIO) - Defense World
Orchestra BioMed Holdings Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
We Think Orchestra BioMed Holdings (NASDAQ:OBIO) Needs To Drive Business Growth Carefully - Yahoo Finance
Orchestra BioMed Reports Q3 2024 Results, Advances Key Clinical Programs - MSN
Orchestra Biomed Reports Q3 2024 Financial Results - TipRanks
Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update - GlobeNewswire
Orchestra BioMed Q3 Revenue Jumps 150%, Extends Cash Runway Despite Wider Losses | OBIO Stock News - StockTitan
Trading (OBIO) With Integrated Risk Controls - Stock Traders Daily
Orchestra BioMed to Participate in Jefferies London Healthcare Conference - The Manila Times
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) market cap surged US$23m last week, individual investors who have a lot riding on the company were rewarded - Simply Wall St
HC Wainwright & Co. Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Buy Recommendation - MSN
Orchestra BioMed Appoints John Mack to Board of Directors - MSN
SkyView Investment Advisors LLC Invests $163,000 in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Rhumbline Advisers Buys 17,405 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Buys 2,500 Shares of Stock - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider David P. Hochman Purchases 2,500 Shares - Defense World
Orchestra BioMed executive acquires shares worth over $47k By Investing.com - Investing.com Australia
Orchestra BioMed executive acquires shares worth over $47k - Investing.com India
Market Update: Ocular Therapeutix Inc (OCUL) Sees Negative Movement, Closing at 8.46 - The Dwinnex
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Bought by Bank of New York Mellon Corp - Defense World
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Shares Sold by Logos Global Management LP - MarketBeat
Elevai Labs shares tumble on pricing of new stock offering - Sacramento Business Journal
Why Elevai Labs (ELAB) Stock Is Down 60% Today - Benzinga
Elevai Labs announces pricing of $8 million public offering - MSN
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering - GlobeNewswire
L’Oreal partners with Evonik and Abolis to scale development of next-gen ingredients - GlobalCosmeticsNews
Video: A WONDERFUL WORLD Parades to Studio 54 - BroadwayWorld
The Cure 'Songs of a Lost World' billboard appears in NYC - Brooklyn Vegan
Exicure Shares More Than Double After Nasdaq Listing Extension - MarketWatch
Oxford Biomedica Emerges as OXB with Global Vision - TipRanks
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of European Wax Center, Inc.EWCZ - PR Newswire
Ocular Therapeutix Inc’s Market Journey: Closing Weak at 8.93, Down -0.78 - The Dwinnex
(OBIO) On The My Stocks Page - Stock Traders Daily
IPO NewsUP IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market - Renaissance Capital
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):